Corrigendum to “Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis” [Biomed. Pharmacother. 97 (330–338) 330–338] (Biomedicine & Pharmacotherapy (2018) 97 (330–338), (S0753332217332328) (10.1016/j.biopha.2017.10.071))

Abstract

The authors regret the authors would like to change the word “Pancreatitis” to “β cells damage” throughout the manuscript, from heading to conclusion. The authors would like to change the third sentence of introduction “Thus, for diabetes progression, it is necessary to prevent the rate of pancreatitis.” to “Thus, for diabetes prevention, it is necessary to reduce the rate of β cells damage.” The authors would like to change the unit of glucose in Animal Design “200 g/dL” to 200 mg/dL.” The authors would like to change the name of secondary antibodies “anti-mouse-AF546 and anti-rabbit-AF488” to “anti-rabbit AF 546 (Red) and anti-mouse AF 488 (Green)” The authors would like to change the last sentence of discussion “All these changes collectively inhibit the apoptosis of pancreatic β cells through downregulation of Bcl 2 and improved insulin synthesis” to “All these changes collectively inhibit the apoptosis of pancreatic β cells through upregulation of Bcl 2 and improved insulin synthesis” The authors would like to apologise for any inconvenience caused. © 2017 Elsevier Masson SAS